Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Johnson and Johnson
Mallinckrodt
QuintilesIMS
Accenture
Daiichi Sankyo
UBS
Julphar
Argus Health
AstraZeneca

Generated: October 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090824

« Back to Dashboard
NDA 090824 describes ADAPALENE, which is a drug marketed by Actavis Mid Atlantic, Glenmark Generics, Taro, Fougera Pharms, Pliva Hrvatska Doo, Call Inc, and Tolmar, and is included in nine NDAs. It is available from twelve suppliers. Additional details are available on the ADAPALENE profile page.

The generic ingredient in ADAPALENE is adapalene; benzoyl peroxide. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.

Summary for NDA: 090824

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 090824

Ingredient-typeRetinoids

Suppliers and Packaging for NDA: 090824

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADAPALENE
adapalene
CREAM;TOPICAL 090824 ANDA E. Fougera & Co. A division of Fougera Pharmaceuticals Inc. 0168-0424 0168-0424-46 1 TUBE in 1 CARTON (0168-0424-46) > 45 g in 1 TUBE
ADAPALENE
adapalene
CREAM;TOPICAL 090824 ANDA Physicians Total Caer, Inc. 54868-6148 54868-6148-0 1 TUBE in 1 CARTON (54868-6148-0) > 45 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.1%
Approval Date:Jun 30, 2010TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Queensland Health
Dow
US Army
Daiichi Sankyo
Cipla
Farmers Insurance
Novartis
Fish and Richardson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot